Title for MeetingAbstracts
Alphabetical listing of titles
Empowerment of HIV+ women.
Empowerment of Malaysian PWA's--issues, barriers and strategies.
Empowerment of needy HIV infected women in Kayole slums of Nairobi through IGA group processes.
Empowerment of patients HIV positive, family and social networks for better assistance and quality of life of all of them.
Empowerment of people living with HIV/AIDS (PLHAs)/active injecting drug user (IDUs) in Peer Support Group.
Empowerment of people living with HIV/AIDS in Gitega Province, Burundi.
Empowerment of people with HIV and AIDS through focused interview technique and newsletter production.
Empowerment of phas to live positively with HIV/AIDS - a personal experience.
Empowerment of subcommittee on provincial AIDS prevention and alleviation response on HIV/AIDS epidemic in 76 provinces, Thailand during 2001-2002.
Empowerment of vulnerable groups for HIV prevention in Ecuador.
Empowerment of young women as to avoid risky behavior.
Empowerment processes to improve the quality of life of people living with HIV/AIDS (PWA).
Empowerment strategies and AIDS prevention among fishermen's wives in San Antonio, Chile.
Empowerment the importance in people living with HIV and AIDS.
Empowerment through Education as a tool in establishing the Rights of the Floating Sex Workers.
Empowerment to the people living with HIV-AIDS about their human rights.
Empowerment training to positive women in Tanzania. Promote the quality of life of women affected.
Empowerment, community mobilization and social change in the face of HIV/AIDS.
Empowerment, self-efficacy, gender and HIV in Tanzania: quantitative and qualitative explorations.
EMR: Less Room for Error?
Emtricitabine (FTC): Activity against Hepatitis B Virus in a Phase I/II Clinical Study.
Emtricitabine (FTC): HBV DNA viral load assessments over 36 weeks in patients with chronic HBV infection.
Emtricitabine Therapy for Hepatitis Infection in HIV+ Patients Co-infected with Hepatitis B Virus: Efficacy and Genotypic Findings in Antiretroviral Treatment-naive Patients.
EMTRICITABINE, DIDANOSINE AND EFAVIRENZ ONCE-DAILY (OD) VERSUS CONTINUED PI-BASED HAART (C) IN HIV-INFECTED ADULTS WITH UNDETECTABLE PLASMA HIV-RNA: 48-WEEK RESULTS OF A PROSPECTIVE RANDOMIZED MULTICENTRE TRIAL (ALIZE-ANRS 99).
Emtricitabine: Summary of Toxicology and Nonclinical Pharmacology Evaluations.
Enablig Catholic clergy to deal with the reality of HIV in their lives.
Enabling Access to Medical Technologies in Developing Countries: The Aurolab Model.
Enabling an informed personal choice about HIV drug treatments.
Enabling Communities Practice Best Practice in Management of HIV/AIDS: using Appreciative Inquiry in Uganda.
Enabling effective and sustainable care pedagogues - a developing country experiment.